CorMedix Inc.
NASDAQ:CRMD
9.99 (USD) • At close November 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0.065 | 0.191 | 0.239 | 0.283 | 0.43 | 0.329 | 0.224 | 0.21 | 0.189 | 0.002 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.206 | 0.004 | 0.149 | 0.205 | 0.373 | 0.397 | 0.115 | 0.367 | 0.319 | 0.446 | 0.202 | 0 | 0 | 0 | 0 |
| Gross Profit
| -0.206 | 0.062 | 0.042 | 0.034 | -0.09 | 0.033 | 0.214 | -0.143 | -0.109 | -0.257 | -0.2 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0.943 | 0.22 | 0.144 | -0.318 | 0.077 | 0.651 | -0.636 | -0.517 | -1.355 | -99.752 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 13.155 | 10.68 | 13.133 | 13.377 | 11.053 | 18.822 | 24.486 | 15.735 | 6.282 | 1.319 | 1.227 | 1.188 | 4.098 | 5.494 | 4.889 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 8.075 | 8.652 | 8.883 | 10.264 | 7.327 | 3.489 | 1.857 | 3.149 | 3.013 | 1.167 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 35.803 | 20.006 | 16.347 | 13.878 | 9.865 | 8.075 | 8.652 | 8.883 | 10.264 | 7.327 | 3.489 | 1.857 | 3.149 | 3.013 | 1.167 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.005 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 48.958 | 30.686 | 29.48 | 27.255 | 20.918 | 26.897 | 33.138 | 24.618 | 16.545 | 8.646 | 4.716 | 3.045 | 7.247 | 8.507 | 6.055 |
| Operating Income
| -48.958 | -30.624 | -29.438 | -27.221 | -21.008 | -26.864 | -32.924 | -24.761 | -16.654 | -8.902 | -4.915 | -3.045 | -7.247 | -8.507 | -6.055 |
| Operating Income Ratio
| 0 | -468.199 | -154.175 | -113.784 | -74.163 | -62.504 | -99.974 | -110.488 | -79.256 | -47.033 | -2,456.469 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 2.619 | 0.337 | -0.023 | 0.024 | -0.486 | -0 | -0.191 | -0.008 | -1.59 | -11.552 | -2.774 | -0.381 | 0.03 | 0.391 | -2.066 |
| Income Before Tax
| -46.339 | -30.287 | -29.46 | -27.197 | -21.494 | -26.83 | -33.01 | -24.644 | -18.188 | -20.453 | -9.133 | -3.426 | -7.205 | -11.186 | -8.121 |
| Income Before Tax Ratio
| 0 | -463.052 | -154.295 | -113.685 | -75.879 | -62.424 | -100.234 | -109.965 | -86.554 | -108.063 | -4,564.267 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| -0 | -0.586 | -1.25 | -5.169 | -5.061 | 0.036 | -0.031 | 0.001 | 0.004 | 0.002 | 1.44 | 0.002 | -0.494 | -0.281 | 0.002 |
| Net Income
| -46.339 | -29.702 | -28.21 | -22.028 | -16.433 | -26.83 | -33.01 | -24.644 | -18.188 | -20.453 | -9.133 | -3.426 | -6.711 | -10.905 | -8.121 |
| Net Income Ratio
| 0 | -454.099 | -147.747 | -92.077 | -58.013 | -62.424 | -100.234 | -109.965 | -86.554 | -108.063 | -4,564.267 | 0 | 0 | 0 | 0 |
| EPS
| -0.91 | -0.74 | -0.75 | -0.77 | -0.68 | -1.51 | -2.99 | -3.25 | -2.9 | -4.77 | -3.3 | -1.5 | -2.94 | -5.76 | -47.4 |
| EPS Diluted
| -0.91 | -0.74 | -0.75 | -0.77 | -0.68 | -1.51 | -2.99 | -3.25 | -2.9 | -4.77 | -3.3 | -1.5 | -2.94 | -5.76 | -47.4 |
| EBITDA
| -48.887 | -30.298 | -29.444 | -27.105 | -20.685 | -26.828 | -32.813 | -24.609 | -16.579 | -8.884 | -4.914 | -3.036 | -7.223 | -8.471 | -6.043 |
| EBITDA Ratio
| 0 | -463.215 | -154.211 | -113.299 | -73.024 | -62.419 | -99.638 | -109.808 | -78.896 | -46.939 | -2,455.812 | 0 | 0 | 0 | 0 |